Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis
Oake N, Jennings A, Forster AJ, Fergusson D, Doucette S, van Walraven C. CMAJ. 2008; 179(3):235-44.
Publications
Outcomes of surveillance mammography after treatment of primary breast cancer: a population-based case series
Paszat L, Sutradhar R, Grunfeld E, Gainford C, Benk V, Bondy S, Coyle D, Holloway C, Sawka C, Shumak R, Vallis K, van Walraven C. Breast Cancer Res Treat. 2009; 114(1):169-78. Epub 2008 Mar 27.
Anticoagulation control in the peri-hospitalization period
van Walraven C, Forster AJ. J Gen Intern Med. 2007; 22(6):727-35. Epub 2007 Mar 31.
Burden of potentially avoidable anticoagulant-associated hemorrhagic and thromobembolic events in the elderly
van Walraven C, Oake N, Wells PS, Forster AJ. Chest. 2007; 131(5):1508-15. Epub 2007 Feb 22.
Effect of provider continuity on test repetition
van Walraven C, Cernat G, Austin PC. Clin Chem. 2006; 52(12):2219-28. Epub 2006 Oct 19.
The effect of hospitalization on oral anticoagulation control: a population-based study
van Walraven C, Austin PC, Oake N, Wells P, Mamdani M, Forster AJ. Thromb Res. 2007; 119(6):705-14. Epub 2006 Jul 17.
Utilization and outcomes of HbA1c testing: a population-based study
Woodward G, van Walraven C, Hux JE. CMAJ. 2006; 174(3):327-9.
Quantifying the impact of survivor treatment bias in observational studies
Austin PC, Mamdani MM, van Walraven C, Tu JV. J Eval Clin Pract. 2006; 12(6):601-12.
Diabetic patients with prior specialist care have better glycaemic control than those with prior primary care
Shah BR, Hux JE, Laupacis A, Mdcm BZ, Austin PC, van Walraven C. J Eval Clin Pract. 2005; 11(6):568-75.
Identifying individuals with reduced GFR using ambulatory laboratory database surveillance
Garg AX, Mamdani M, Juurlink DN, van Walraven C; Network of Eastern Ontario Medical Laboratories (NEO-MeL). J Am Soc Nephrol. 2005; 16(5):1433-9. Epub 2005 Mar 30.